These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26392096)

  • 1. International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme.
    Roa W; Kepka L; Kumar N; Sinaika V; Matiello J; Lomidze D; Hentati D; Guedes de Castro D; Dyttus-Cebulok K; Drodge S; Ghosh S; Jeremić B; Rosenblatt E; Fidarova E
    J Clin Oncol; 2015 Dec; 33(35):4145-50. PubMed ID: 26392096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Outcomes With Short-Course Radiation Therapy in Elderly Patients With Glioblastoma: Data From a Randomized Phase 3 Trial.
    Guedes de Castro D; Matiello J; Roa W; Ghosh S; Kepka L; Kumar N; Sinaika V; Lomidze D; Hentati D; Rosenblatt E; Fidarova E
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):931-938. PubMed ID: 28602417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Study of Short Course (One Week) Radiation Therapy with or without Temozolomide in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma (GBM).
    Thakur S; Kumar N; Salunke P; Ahuja C; Madan R
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2317-2323. PubMed ID: 35901337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
    Jackson WC; Tsien CI; Junck L; Leung D; Hervey-Jumper S; Orringer D; Heth J; Wahl DR; Spratt DE; Cao Y; Lawrence TS; Kim MM
    J Neurooncol; 2018 May; 138(1):155-162. PubMed ID: 29388034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis.
    Navarria P; Pessina F; Cozzi L; Tomatis S; Reggiori G; Simonelli M; Santoro A; Clerici E; Franzese C; Carta G; Conti Nibali M; Bello L; Scorsetti M
    Tumori; 2019 Feb; 105(1):47-54. PubMed ID: 30131010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma.
    Ghosh S; Baker S; de Castro DG; Kepka L; Kumar N; Sinaika V; Matiello J; Lomidze D; Dyttus-Cebulok K; Rosenblatt E; Fidarova E; Roa W
    Radiother Oncol; 2018 Apr; 127(1):114-120. PubMed ID: 29452901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.
    Roa W; Brasher PM; Bauman G; Anthes M; Bruera E; Chan A; Fisher B; Fulton D; Gulavita S; Hao C; Husain S; Murtha A; Petruk K; Stewart D; Tai P; Urtasun R; Cairncross JG; Forsyth P
    J Clin Oncol; 2004 May; 22(9):1583-8. PubMed ID: 15051755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
    Malmström A; Grønberg BH; Marosi C; Stupp R; Frappaz D; Schultz H; Abacioglu U; Tavelin B; Lhermitte B; Hegi ME; Rosell J; Henriksson R;
    Lancet Oncol; 2012 Sep; 13(9):916-26. PubMed ID: 22877848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
    Gállego Pérez-Larraya J; Ducray F; Chinot O; Catry-Thomas I; Taillandier L; Guillamo JS; Campello C; Monjour A; Cartalat-Carel S; Barrie M; Huchet A; Beauchesne P; Matta M; Mokhtari K; Tanguy ML; Honnorat J; Delattre JY
    J Clin Oncol; 2011 Aug; 29(22):3050-5. PubMed ID: 21709196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 1999 Aug; 44(1):85-90. PubMed ID: 10582674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
    Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
    Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.
    Fariselli L; Pinzi V; Milanesi I; Silvani A; Marchetti M; Farinotti M; Salmaggi A
    Strahlenther Onkol; 2013 Jun; 189(6):456-61. PubMed ID: 23625362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
    Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.
    Bauman GS; Gaspar LE; Fisher BJ; Halperin EC; Macdonald DR; Cairncross JG
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):835-9. PubMed ID: 8040031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.